Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3813 USD | -7.05% | -12.41% | -97.92% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.99M 166M |
---|---|---|---|---|---|
Net income 2024 * | -26M -2.17B | Net income 2025 * | -34M -2.84B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.08
x | P/E ratio 2025 * |
-0.09
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Panbela Therapeutics, Inc.
1 day | -7.05% | ||
1 week | -12.41% | ||
Current month | -11.33% | ||
1 month | -29.34% | ||
3 months | -68.22% | ||
6 months | -97.31% | ||
Current year | -97.92% |
Date | Price | Change | Volume |
---|---|---|---|
06/24/06 | 0.3813 | -7.05% | 16 517 |
03/24/03 | 0.4102 | +7.58% | 49,422 |
02/24/02 | 0.3813 | -7.00% | 61,762 |
01/24/01 | 0.41 | -4.65% | 50,329 |
30/24/30 | 0.43 | -1.21% | 25,578 |
Delayed Quote OTC Markets, May 06, 2024 at 07:56 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-97.92% | 1.99M | |
+21.76% | 47.9B | |
+46.62% | 41.42B | |
-2.18% | 40.7B | |
-6.20% | 28.92B | |
+10.19% | 25.55B | |
-20.87% | 19.27B | |
-0.32% | 12.15B | |
+31.04% | 12.14B | |
-0.47% | 11.99B |
- Stock Market
- Equities
- SNBP Stock